Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2‐093), a new voltage‐gated sodium channel blocker
Purpose. To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage‐gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage‐gated sodium channel blocker in the development for the treatment …
Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker
A Falcão, J Maia, L Almeida… - … & drug disposition, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
A Falcão, J Maia, L Almeida, D Mazur… - … & Drug Disposition, 2007 - europepmc.org
Purpose To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
[PDF][PDF] Effect of Gender on the Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093), a New Voltage-gated Sodium Channel Blocker
A Falcaoa, J Maiaa, L Almeidaa, D Mazurb… - Biopharm. Drug …, 2007 - Citeseer
Purpose. To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
[PDF][PDF] Effect of Gender on the Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093), a New Voltage-gated Sodium Channel Blocker
A Falcaoa, J Maiaa, L Almeidaa, D Mazurb… - Biopharm. Drug …, 2007 - academia.edu
Purpose. To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
[PDF][PDF] Effect of Gender on the Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093), a New Voltage-gated Sodium Channel Blocker
A Falcaoa, J Maiaa, L Almeidaa, D Mazurb… - Biopharm. Drug …, 2007 - core.ac.uk
Purpose. To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
Effect of Gender on the Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093), a New Voltage-gated Sodium Channel Blocker
A Falcão, J Maia, L Almeida, D Mazur, M Gellert… - 2007 - estudogeral.uc.pt
Purpose. To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
[PDF][PDF] Effect of Gender on the Pharmacokinetics of Eslicarbazepine Acetate (BIA 2-093), a New Voltage-gated Sodium Channel Blocker
A Falcaoa, J Maiaa, L Almeidaa, D Mazurb… - Biopharm. Drug …, 2007 - academia.edu
Purpose. To determine the effect of gender on the pharmacokinetics of eslicarbazepine
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …
acetate, a novel voltage-gated sodium channel blocker in the development for the treatment …